quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 1, 2026

Warsh’s Return Revives Tensions Over the Fed’s $6.6 Trillion QE Hangover

View original at finance.yahoo.com
Warsh’s Return Revives Tensions Over the Fed’s $6.6 Trillion QE Hangover Photographer: Tierney L…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Demand for bank reserves and Fed balance sheet size is determined by banks' regulatory and internal liquidity needs

    80% confidence
  • If Warsh dislikes balance sheet expansion as a way to compress yields, then responsibility falls onto Treasury

    80% confidence
  • Run printing press less, let balance sheet come down, let Treasury handle fiscal accounts to achieve materially lower interest rates

    80% confidence
  • Kevin Warsh has been very critical of the Fed's balance sheet expansion

    80% confidence
  • There is a bit of wiggle room within Fed definition of ample reserves

    80% confidence
  • Fed can move short rate to offset balance sheet actions; shrinking balance sheet on principle allows offsetting rate cuts if long rates increase

    80% confidence
  • Need new Treasury-Fed accord like 1951 where Fed chair and Treasury secretary describe objective for Fed balance sheet size to markets

    80% confidence
  • For now it's status quo, but markets will remain on edge until Warsh makes his views clearer

    80% confidence
  • Addition of another balance-sheet hawk on FOMC should help keep check on future asset purchases or reinvestment policies

    80% confidence
  • Significantly smaller balance sheet would likely require major shift in Fed's existing bank regulatory framework

    80% confidence
  • Aggressive bond buying artificially depressed borrowing rates for extended periods, fanned Wall Street risk-taking and encouraged lawmakers to pile on more debt

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com